Total Funding
56
44
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
141875
Precision Virologics is a St. Louis-based biotech startup.
- Daniel Katzman: CEOPast Role: NeuroHealing Pharmaceuticals, President
David T. Curiel: Founder & CSOPast Role: University of Alabama at Birmingham, Director
About the Company
Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. PV-ZIKV, our vaccine candidate for Zika, has significant advantages over competitors, including the lack of cross-reactivity among flaviviruses and increased potency
